| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 33.7× | −1.7× | |
| Price / Book | 1.5× | 2.0× | |
| Price / Sales | 3.2× | 4.0× | |
| Price / Free cash flow | 20.6× | −1.6× | |
| EV / EBITDA | 15.6× | −1.2× | |
| Earnings yield | 3.0% | −14.6% | |
| Free cash flow yield | 4.9% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,247.87 | −0.73% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.44 | −0.83% | $610.76B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.78 | −0.57% | $501.47B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.80 | +0.34% | $361.55B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.55 | −0.96% | $356.63B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.37 | −0.17% | $278.17B | 19.8× | 30.5% |
| +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.13 | −0.17% | $256.1B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $676.81 | −1.91% | $250.25B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.92 | −1.06% | $231.35B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.57 | −1.04% | $191.66B | 22.8× | 37.5% | +32.0% |
